Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy

Kidney cancer is the 7th most prevalent form of cancer in the United States with the vast majority of cases being classified as renal cell carcinoma (RCC). Multiple targeted therapies have been developed to treat RCC, but efficacy and resistance remain a challenge. In recent years, the modulation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Trace M., Carew, Jennifer S., Nawrocki, Steffan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281213/
https://www.ncbi.nlm.nih.gov/pubmed/32392870
http://dx.doi.org/10.3390/cancers12051185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281213/
https://www.ncbi.nlm.nih.gov/pubmed/32392870
http://dx.doi.org/10.3390/cancers12051185

Ejemplares similares